Health News
Date: Jun-22-2012
A protein required to regrow injured peripheral nerves has been identified by researchers at Washington University School of Medicine in St. Louis. The finding, in mice, has implications for improving recovery after nerve injury in the extremities. It also opens new avenues of investigation toward triggering nerve regeneration in the central nervous system, notorious for its inability to heal. Peripheral nerves provide the sense of touch and drive the muscles that move arms and legs, hands and feet...
Date: Jun-22-2012
With a single drug treatment, researchers at the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine can silence the mutated gene responsible for Huntington's disease, slowing and partially reversing progression of the fatal neurodegenerative disorder in animal models. The findings are published in the online issue of the journal Neuron. Researchers suggest the drug therapy, tested in mouse and non-human primate models, could produce sustained motor and neurological benefits in human adults with moderate and severe forms of the disorder...
Date: Jun-22-2012
Regenerative Medicine Institute research sheds new light on cell death in a common, lethal genetic disease in children, suggesting paths for potential treatment Cedars-Sinai's Regenerative Medicine Institute has pioneered research on how motor-neuron cell-death occurs in patients with spinal muscular atrophy, offering an important clue in identifying potential medicines to treat this leading genetic cause of death in infants and toddlers...
Date: Jun-22-2012
Women who experience an initial ectopic pregnancy-when the embryo implants outside the womb, usually in the fallopian tubes - are less likely to conceive in the future and if they do, are at increased risk of having another ectopic pregnancy, but are no more likely than first time mothers to suffer complications in an ongoing pregnancy according to a study by a team of Scottish researchers published today in PLoS Medicine...
Date: Jun-22-2012
Scientists have examined strategies to reverse the effects of new blood thinning drugs, to stop dangerous bleeding in case of an accident or emergency surgery. Many people in the UK take blood thinning drugs to reduce their risk of stroke. In an emergency situation, where a patient is likely to bleed heavily, doctors need to reverse the blood thinning effects and encourage the blood to clot. In this study, researchers added apixaban, a new blood thinner, to blood from healthy donors. They then tested the blood with three clotting agents...
Date: Jun-22-2012
A University of Pittsburgh School of Medicine study reports that adolescents understand how sexually transmitted diseases (STD) occur, and they actively attempt to reduce their risk but do so by developing ineffective practices. The findings are reported online this week in Perspectives on Sexual and Reproductive Health...
Date: Jun-22-2012
Featured in the May edition of the Journal of Obstetrics and Gynaecology Canada is a new guide to help doctors, nurses and midwives counsel their patients about prenatal genetic screening. One of the greatest sources of stress for expectant parents is their concern about the health of their baby. While prenatal screening can help provide parents with some insight into the condition of the foetus the mother is carrying, expectations must be carefully managed...
Date: Jun-22-2012
Featured in the June edition of the Journal of Obstetrics and Gynaecology Canada is a new clinical practice guideline to help doctors, nurses and midwives assist HIV-positive individuals or couples with their fertility and pregnancy planning decisions. People with HIV are now living longer and healthier lives than they were even a decade ago. This is mostly due to advances in medical treatments, such as the development of combined antiretroviral therapy (cART). With this change in life expectancy and quality of life has come an increasing number of pregnancies for HIV-positive Canadians...
Date: Jun-22-2012
Blood pressure reductions statistically superior to olmesartan medoxomil-hydrochlorothiazide Results of a 12-week, head-to-head, phase 3 study published online in the American Heart Association journal Hypertension found systolic blood pressure (SBP) reductions of a fixed-dose combination of azilsartan medoxomil and chlorthalidone 40/25 mg were statistically superior to those of the fixed-dose combination of olmesartan medoxomil-hydrochlorothiazide 40/25 mg. This fixed-dose combination (azilsartan medoxomil and chlorthalidone) is currently marketed as Edarbyclor in the United States...
Date: Jun-21-2012
A survey published in the June edition of Archives of Surgery reveals that many surgical interns believe that new duty-hour restrictions will have several consequences, including not being able to gain as much medical knowledge, having less time to develop surgical skills and overall educational experience, but also having less continuity with patients, time spent operating and coordination of care...